Currently viewing: Our geographic footprint / Next: Our investment proposition
Life Healthcare provides quality healthcare to the southern Africa market, which includes South Africa and Botswana. Our primary service offering is organised into two divisions – namely, the hospital division and the healthcare services division.
Alliance Medical, Europe’s leading independent provider of complex diagnostic imaging services, integrated molecular imaging services and manufacturing of radiopharmaceuticals.
| Southern Africa | 2020 | 2019 |
| Revenue | R17.2 billion | R18.5 billion |
|---|---|---|
| Earnings before interest, tax, depreciation and amortisation (EBITDA) pre-IFRS 16 | R2.8 billion | R4.4 billion |
| Number of paid patient days (PPDs) | 1 914 159 | 2 269 756 |
| Number of permanent employees | 15 060 | 15 385 |
Southern Africa locations
Hospitals and same-day surgical centres
Rehabilitation units
Mental health facilities
Employee Health solutions
Renal dialysis units
Esidimeni units
Specialised maternity unit
College of learning centres
Oncology units
| 2020 | 2019 | |
| Revenue | R6.3 billion | R5.6 billion |
|---|---|---|
| EBITDA pre-IFRS 16 | R1.2 billion | R1.3 billion |
| Number of locations served | 233 | 220 |
| Number of permanent employees | 2 160 | 2 040 |
Scanmed operates across Poland and offers comprehensive medical services in acute facilities, cardiac centres, monoclinics and outpatient facilities.
| 2020 | 2019 | |
| Revenue | R1 535 million | R1 349 million |
|---|---|---|
| EBITDA pre-IFRS 16 | R140 million | R97 million |
| Number of permanent employees | 1 887 | 2 020 |
LMI is a research and development company dedicated to the development and global commercialisation of innovative molecular imaging agents for use in PET-CT diagnostics, addressing major unmet clinical needs in neurological, oncological, and cardiovascular diseases. LMI currently have active supply sites in 20 countries.
| LMI | 2020 | 2019 |
| Revenue | R319 million | R268 million |
|---|---|---|
| EBITDA pre-IFRS 16 | R1 million | (R12 million) |
1 Excludes non-trading foreign exchange loss of R8 million (2019: R30 million profit).